Stonehouse Jon P (CIK 1385496) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-02). Recent activity: Buy BCRX (644 shares), Buy BCRX (15,294 shares), Buy BCRX (631 shares), Buy BCRX (421 shares), Buy BCRX (305,995 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 644 | $6,247 |
| 2026-06-15 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 15,294 | $0 |
| 2026-06-02 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 631 | $5,622 |
| 2026-03-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 421 | $3,684 |
| 2026-03-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Buy | 305,995 | $985,304 |
| 2026-03-03 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Director | Sell | 305,995 | $2.6M |
| 2025-12-23 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Chief Executive Officer | Sell | 61,793 | $457,886 |
| 2025-12-19 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Chief Executive Officer | Sell | 20,000 | $0 |
| 2025-12-19 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Chief Executive Officer | Buy | 10,000 | $0 |
| 2025-12-19 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Chief Executive Officer | Buy | 10,000 | $0 |
| 2025-12-16 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Chief Executive Officer | Sell | 27,368 | $207,176 |
| 2025-11-13 | Metsera, Inc. (MTSR) | Director | Sell | 2,688 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02